Biblio Discovery — Demo Discovery Service

2 results for "P. Hoeflich"

Showing 1–2 · 0.37 seconds · RSS

  1. Journal Article Full text

    Combined Targeting of BRAF and CRAF or BRAF and PI3K Effector Pathways Is Required for Efficacy in NRAS Mutant Tumors

    Bijay S. Jaiswal; Vasantharajan Janakiraman; Noelyn M. Kljavin et al.

    PLoS ONE, Vol. 4 No. 5 · 2009 · English · PLOS Scopus

    Background: Oncogenic RAS is a highly validated cancer target. Attempts at targeting RAS directly have so far not succeeded in the clinic. Understanding downstream RAS-effectors that mediate oncogenesis in a RAS mutant setting will help tailor treatments that use RAS-effector inhibitors either…

  2. Journal Article Full text

    Active PI3K Pathway Causes an Invasive Phenotype Which Can Be Reversed or Promoted by Blocking the Pathway at Divergent Nodes

    Jeffrey J. Wallin; Jane Guan; Kyle A. Edgar et al.

    PLoS ONE, Vol. 7 No. 5 · 2012 · English · PLOS Scopus

    The PTEN/PI3K pathway is commonly mutated in cancer and therefore represents an attractive target for therapeutic intervention. To investigate the primary phenotypes mediated by increased pathway signaling in a clean, patient-relevant context, an activating PIK3CA mutation (H1047R) was knocked-in…